therapeutic target

mTORC2 Controls Actin Polymerization Required for Consolidation of Long-Term Memory.

Published March 5, 2013

mTORC2 controls actin polymerization required for consolidation of long-term memory.

Nat Neurosci. 2013 Mar 3;
Huang W, Zhu PJ, Zhang S, Zhou H, Stoica L, Galiano M, Krnjevi? K, Roman G, Costa-Mattioli M

A major goal of biomedical research… Continue reading →

Drug and Alcohol Rehabilitation: Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process.

Published February 19, 2013

Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2013; 8(2): e56320
Geng Y, Yang J, Huang W, Harrison TJ, Zhou Y,… Continue reading →

Proteomic Profiling of Trastuzumab (Herceptin(R))-Sensitive and -Resistant SKBR-3 Breast Cancer Cells.

Published February 10, 2013

Proteomic Profiling of Trastuzumab (Herceptin(R))-sensitive and -resistant SKBR-3 Breast Cancer Cells.

Filed under: Drug and Alcohol Rehabilitation

Anticancer Res. 2013 Feb; 33(2): 489-503
DI Cara G, Marengo G, Albanese NN, Marabeti MR, Musso R, Cancemi P, Pucci-Minafra I

The… Continue reading →

Temporal Organization as a Therapeutic Target.

Published February 9, 2013

Temporal organization as a therapeutic target.

Filed under: Depression Treatment

Dialogues Clin Neurosci. 2012 Dec; 14(4): 335-7
Wirz-Justice A

Biological functions occur at many different frequencies, and each has its healthy and pathological ranges, patterns, and properties. Physiology, biochemistry,… Continue reading →

Drug and Alcohol Rehabilitation: Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process.

Proteomic Profiling of Trastuzumab (Herceptin(R))-Sensitive and -Resistant SKBR-3 Breast Cancer Cells.

Recent Posts

Search this Site